112 related articles for article (PubMed ID: 31563266)
1. Improvement of the anti-proliferative activity of the peptide ERα17p in MCF-7 breast cancer cells using nanodiamonds.
Yip F; Nemati F; El Botty R; Belnou M; Decaudin D; Mansuy C; Jacquot Y
Ann Pharm Fr; 2019 Nov; 77(6):488-495. PubMed ID: 31563266
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology.
Trichet M; Lappano R; Belnou M; Salazar Vazquez LS; Alves I; Ravault D; Sagan S; Khemtemourian L; Maggiolini M; Jacquot Y
Cells; 2020 Feb; 9(2):. PubMed ID: 32075246
[TBL] [Abstract][Full Text] [Related]
3. The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice.
Mallet C; Boudieu L; Lamoine S; Coudert C; Jacquot Y; Eschalier A
Front Endocrinol (Lausanne); 2021; 12():578250. PubMed ID: 33815268
[TBL] [Abstract][Full Text] [Related]
4. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.
Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
[TBL] [Abstract][Full Text] [Related]
5. Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.
Notas G; Kampa M; Pelekanou V; Troullinaki M; Jacquot Y; Leclercq G; Castanas E
Mol Oncol; 2013 Jun; 7(3):595-610. PubMed ID: 23474223
[TBL] [Abstract][Full Text] [Related]
6. Trophic effect in MCF-7 cells of ERalpha17p, a peptide corresponding to a platform regulatory motif of the estrogen receptor alpha--underlying mechanisms.
Gallo D; Haddad I; Duvillier H; Jacquemotte F; Laïos I; Laurent G; Jacquot Y; Vinh J; Leclercq G
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):138-49. PubMed ID: 18262408
[TBL] [Abstract][Full Text] [Related]
7. ERα17p, an ERα P295 -T311 fragment, modifies the migration of breast cancer cells, through actin cytoskeleton rearrangements.
Kampa M; Pelekanou V; Gallo D; Notas G; Troullinaki M; Pediaditakis I; Charalampopoulos I; Jacquot Y; Leclercq G; Castanas E
J Cell Biochem; 2011 Dec; 112(12):3786-96. PubMed ID: 21826705
[TBL] [Abstract][Full Text] [Related]
8. ERα17p, a peptide reproducing the hinge region of the estrogen receptor α associates to biological membranes: A biophysical approach.
Byrne C; Khemtémourian L; Pelekanou V; Kampa M; Leclercq G; Sagan S; Castanas E; Burlina F; Jacquot Y
Steroids; 2012 Aug; 77(10):979-87. PubMed ID: 22426414
[TBL] [Abstract][Full Text] [Related]
9. The estrogen receptor alpha-derived peptide ERα17p (P(295)-T(311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status.
Pelekanou V; Kampa M; Gallo D; Notas G; Troullinaki M; Duvillier H; Jacquot Y; Stathopoulos EN; Castanas E; Leclercq G
Mol Oncol; 2011 Feb; 5(1):36-47. PubMed ID: 21163714
[TBL] [Abstract][Full Text] [Related]
10. Concentration-dependent and surface-assisted self-assembly properties of a bioactive estrogen receptor α-derived peptide.
Ruggeri FS; Byrne C; Khemtemourian L; Ducouret G; Dietler G; Jacquot Y
J Pept Sci; 2015 Feb; 21(2):95-104. PubMed ID: 25530026
[TBL] [Abstract][Full Text] [Related]
11. Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action.
Jouffre B; Acramel A; Belnou M; Santolla MF; Talia M; Lappano R; Nemati F; Decaudin D; Khemtemourian L; Liu WQ; Maggiolini M; Eschalier A; Mallet C; Jacquot Y
Sci Rep; 2023 Jan; 13(1):1326. PubMed ID: 36693877
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Cell-Specific Mitochondria-Targeted Drug Delivery by Dual-Ligand-Functionalized Nanodiamonds Circumvent Drug Resistance.
Chan MS; Liu LS; Leung HM; Lo PK
ACS Appl Mater Interfaces; 2017 Apr; 9(13):11780-11789. PubMed ID: 28291330
[TBL] [Abstract][Full Text] [Related]
13. Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.
Kampa M; Lappano R; Grande F; Rizzuti B; Maggiolini M; Castanas E; Jacquot Y
Cells; 2023 Feb; 12(4):. PubMed ID: 36831322
[TBL] [Abstract][Full Text] [Related]
14. Dendrimer-Functionalized Nanodiamonds as Safe and Efficient Drug Carriers for Cancer Therapy: Nucleus Penetrating Nanoparticles.
Patil S; Mishra VS; Yadav N; Reddy PC; Lochab B
ACS Appl Bio Mater; 2022 Jul; 5(7):3438-3451. PubMed ID: 35754387
[TBL] [Abstract][Full Text] [Related]
15. Facile modification of nanodiamonds with hyperbranched polymers based on supramolecular chemistry and their potential for drug delivery.
Huang H; Liu M; Jiang R; Chen J; Mao L; Wen Y; Tian J; Zhou N; Zhang X; Wei Y
J Colloid Interface Sci; 2018 Mar; 513():198-204. PubMed ID: 29153713
[TBL] [Abstract][Full Text] [Related]
16. The sequence Pro295-Thr311 of the hinge region of oestrogen receptor α is involved in ERK1/2 activation via GPR30 in leiomyoma cells.
Leiber D; Burlina F; Byrne C; Robin P; Piesse C; Gonzalez L; Leclercq G; Tanfin Z; Jacquot Y
Biochem J; 2015 Nov; 472(1):97-109. PubMed ID: 26371374
[TBL] [Abstract][Full Text] [Related]
17. Delivery of Amonafide from Fructose-Coated Nanodiamonds by Oxime Ligation for the Treatment of Human Breast Cancer.
Zhao J; Lu M; Lai H; Lu H; Lalevée J; Barner-Kowollik C; Stenzel MH; Xiao P
Biomacromolecules; 2018 Feb; 19(2):481-489. PubMed ID: 29316394
[TBL] [Abstract][Full Text] [Related]
18. Nanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systems.
Kaur R; Badea I
Int J Nanomedicine; 2013; 8():203-20. PubMed ID: 23326195
[TBL] [Abstract][Full Text] [Related]
19. Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer.
Xiao J; Duan X; Yin Q; Zhang Z; Yu H; Li Y
Biomaterials; 2013 Dec; 34(37):9648-56. PubMed ID: 24016858
[TBL] [Abstract][Full Text] [Related]
20. Polyamidoamine-Decorated Nanodiamonds as a Hybrid Gene Delivery Vector and siRNA Structural Characterization at the Charged Interfaces.
Lim DG; Rajasekaran N; Lee D; Kim NA; Jung HS; Hong S; Shin YK; Kang E; Jeong SH
ACS Appl Mater Interfaces; 2017 Sep; 9(37):31543-31556. PubMed ID: 28853284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
